World's Best Scientists 2026 revealed!
Dirk Kuypers

Dirk Kuypers

D-Index & Metrics

Medicine

D-Index
94
Citations
26785
World Ranking
10610
National Ranking
124

Overview

Dirk Kuypers is affiliated with KU Leuven in Belgium, focusing primarily on medical research with a specialization in transplantation. Their work encompasses multiple subfields such as transplantation, surgery, nephrology, epidemiology, and infectious diseases. The main field of study is medicine, with a substantial number of publications related to renal transplantation outcomes and treatments.

Their research topics include:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • Transplantation: Methods and Outcomes
  • Cytomegalovirus and herpesvirus research
  • Organ Donation and Transplantation
  • Renal and Vascular Pathologies
  • Neurological Complications and Syndromes

Frequent co-authors collaborating with Dirk Kuypers are:

  • Maarten Naesens
  • Maarten Coemans
  • Elisabet Van Loon
  • Ben Sprangers
  • Aleksandar Senev

Common publication venues where Dirk Kuypers's work appears include:

  • Nephrology Dialysis Transplantation
  • American Journal of Transplantation
  • Journal of the American Society of Nephrology
  • Transplantation
  • Kidney International

Notable recent papers authored or co-authored by Dirk Kuypers feature studies published between 2020 and 2023, covering various aspects of kidney transplantation and related fields:

  • "Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study" (2020) - Journal of the American Society of Nephrology
  • "Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial" (2020) - The Lancet
  • "Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients" (2023) - JAMA
  • "Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial" (2023) - The Lancet
  • "Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection" (2023) - Nature Communications

Best Publications

  • Calcineurin Inhibitor Nephrotoxicity

    Maarten Naesens;Dirk R. J. Kuypers;Minnie Sarwal

  • Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.

    Pierre Wallemacq;Victor W Armstrong;Merce Brunet;Vincent Haufroid

  • Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

    V Fremeaux-Bacchi;MA Dragon-Durey;J Blouin;C Vigneau

  • Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

    Teun van Gelder;Yann Le Meur;Leslie M Shaw;Michael Oellerich

  • Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study

    Pieter Evenepoel;Kathleen Claes;Dirk Kuypers;Bart Maes

  • Diagnosis and prevention of chronic kidney allograft loss

    Brian J Nankivell;Dirk R J Kuypers

  • p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease

    Björn K.I. Meijers;Kathleen Claes;Bert Bammens;Henriette de Loor

  • Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

    Dirk R.J. Kuypers;Yannick Le Meur;Marcelo Cantarovich;Michael J. Tredger

  • Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

    Teun van Gelder;Helio Tedesco Silva;Johan W. de Fijter;Klemens Budde

  • Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.

    James M. Neuberger;Wolf O. Bechstein;Dirk R.J. Kuypers;Patrizia Burra

  • Effect of histological damage on long-term kidney transplant outcome.

    Brian J. Nankivell;Carol A. Fenton-Lee;Dirk R. J. Kuypers;Elaine Cheung

  • Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

    F Vincenti;E Ramos;C Brattstrom;S Cho

  • Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

    Alexandre Loupy;Olivier Aubert;Babak J. Orandi;Maarten Naesens

  • Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

    Bart D. Maes;Raymond Oyen;Kathleen Claes;Pieter Evenepoel

  • Connective tissue growth factor (CTGF) from basics to clinics

    Yasaman Ramazani;Noël Knops;Mohamed A. Elmonem;Tri Q. Nguyen

  • Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015

    Maarten Coemans;Caner Süsal;Bernd Döhler;Dany Anglicheau

  • Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

    Štefan Vítko;Raimund Margreiter;Willem Weimar;Jacques Dantal

  • Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring

    Dirk R.J. Kuypers;Patrick C. Peeters;Jacques J. Sennesael;Mireille N. Kianda

  • Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

    Maarten Naesens;Dirk R J Kuypers;Kristin Verbeke;Yves Vanrenterghem

  • Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long-term Pharmacokinetics in de Novo Renal Allograft Recipients

    Dirk R. J. Kuypers;Kathleen Claes;Pieter Evenepoel;Bart Maes

Frequent Co-Authors

Kathleen Claes
Kathleen Claes Ghent University Hospital
Klemens Budde
Klemens Budde Charité - University Medicine Berlin
Teun van Gelder
Teun van Gelder Leiden University Medical Center
Tim S. Nawrot
Tim S. Nawrot Hasselt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean following the traditional MD path. Many students pursue alternative routes through online graduate programs that expand their opportunities in healthcare. These programs offer flexibility, and can often be more affordable and accessible.

For those interested in healthcare management, online mha programs affordable provide strong preparation for leadership roles in hospitals, clinics, and healthcare systems. If you’re a registered nurse seeking advanced practice or leadership roles, the best online bsn to dnp programs offer pathways to earn a Doctor of Nursing Practice.

Pharmacists are vital members of the healthcare team, and you can now qualify through accredited online pharmacist programs. Additionally, with the rise of digital health, there is growing demand for specialists in electronic medical records and data management. Accredited health information technology programs online are a great option for those wanting a non-clinical but equally vital health career.

By exploring these online degree options, you can diversify your education and open doors to fulfilling roles within the expanding healthcare sector.

Best Scientists Citing Dirk Kuypers

Trending Scientists